JP2013500713A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013500713A5 JP2013500713A5 JP2012522282A JP2012522282A JP2013500713A5 JP 2013500713 A5 JP2013500713 A5 JP 2013500713A5 JP 2012522282 A JP2012522282 A JP 2012522282A JP 2012522282 A JP2012522282 A JP 2012522282A JP 2013500713 A5 JP2013500713 A5 JP 2013500713A5
- Authority
- JP
- Japan
- Prior art keywords
- hepatitis
- subject
- infected
- involuntary
- polymorphic marker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH01201/09 | 2009-07-31 | ||
| CH12012009 | 2009-07-31 | ||
| US28253810P | 2010-02-26 | 2010-02-26 | |
| US61/282,538 | 2010-02-26 | ||
| PCT/IB2010/053139 WO2011013019A1 (en) | 2009-07-31 | 2010-07-09 | Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013500713A JP2013500713A (ja) | 2013-01-10 |
| JP2013500713A5 true JP2013500713A5 (enExample) | 2013-08-15 |
Family
ID=42727569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522282A Pending JP2013500713A (ja) | 2009-07-31 | 2010-07-09 | Ｈｃｖ感染患者においてｃ型肝炎の転帰を診断又は予測する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110165124A1 (enExample) |
| EP (1) | EP2459210A1 (enExample) |
| JP (1) | JP2013500713A (enExample) |
| KR (1) | KR20120040725A (enExample) |
| CN (1) | CN102665753A (enExample) |
| AU (1) | AU2010277239A1 (enExample) |
| BR (1) | BR112012001931A2 (enExample) |
| CA (1) | CA2768772A1 (enExample) |
| MX (1) | MX2012001058A (enExample) |
| WO (1) | WO2011013019A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5656159B2 (ja) * | 2009-08-24 | 2015-01-21 | 独立行政法人理化学研究所 | インターフェロン療法の効果予測用マーカー |
| BR112012018342A2 (pt) * | 2009-12-22 | 2017-01-10 | Janssen R&D Ireland | "valor de previsão do polimorfismo do gene il28b combinado com a quantificação de ip-10 no soro pré-tratamento para resposta ao peginterferon e à ribavirina aprimorada em relação a qualquer desses biomarcadores isoladamente." |
| WO2012107584A1 (en) | 2011-02-11 | 2012-08-16 | Universite Pierre Et Marie Curie (Paris 6) | Methods for predicting outcome of a hepatitis virus infection |
| KR20140007927A (ko) * | 2011-03-31 | 2014-01-20 | 노파르티스 아게 | C형 간염 바이러스 감염을 치료하기 위한 알리스포리비르 |
| EP2726632A1 (en) * | 2011-06-30 | 2014-05-07 | Centre Hospitaller Universitaire Vaudois (CHUV) | Polymorphisms associated with non-response to a hepatitis c treatment or susceptibility to non-spontaneous hepatitis c clearance |
| BR112014002365A2 (pt) | 2011-08-03 | 2017-02-21 | Cytheris | interleucina-7 (il-7) |
| JP2013074888A (ja) * | 2011-09-15 | 2013-04-25 | Arkray Inc | ＩＬ２８Ｂ（ｒｓ８０９９９１７）とＩＴＰＡ（ｒｓ１１２７３５４）の変異を検出する方法 |
| WO2013052862A1 (en) * | 2011-10-05 | 2013-04-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Genetic marker for predicting prognosis in patients infected with hepatitis c virus |
| US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
| DE112012003510T5 (de) | 2011-10-21 | 2015-03-19 | Abbvie Inc. | Verfahren zur Behandlung von HCV umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin aber nicht Interferon |
| CN104023726A (zh) | 2011-10-21 | 2014-09-03 | 艾伯维公司 | 用于治疗hcv的一种或多种daa的联合治疗(例如，与abt-072或abt-333) |
| US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
| US9678074B2 (en) | 2012-03-28 | 2017-06-13 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Interferon-λ4 (IFNL4) protein, related nucleic acid molecules, and uses thereof |
| CN102816838A (zh) * | 2012-07-06 | 2012-12-12 | 吉林艾迪康医学检验所有限公司 | 用于检测丙型肝炎患者il28b snp12980275多态性的试剂盒 |
| JP7129703B2 (ja) | 2016-04-28 | 2022-09-02 | エモリー ユニバーシティー | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 |
| CN108220424A (zh) * | 2018-02-05 | 2018-06-29 | 广州和康医疗技术有限公司 | 一种检测il28基因位点的方法及试剂盒 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5001050A (en) | 1989-03-24 | 1991-03-19 | Consejo Superior Investigaciones Cientificas | PHφ29 DNA polymerase |
| US5846717A (en) | 1996-01-24 | 1998-12-08 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
| US5888780A (en) | 1992-12-07 | 1999-03-30 | Third Wave Technologies, Inc. | Rapid detection and identification of nucleic acid variants |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| US6045996A (en) | 1993-10-26 | 2000-04-04 | Affymetrix, Inc. | Hybridization assays on oligonucleotide arrays |
| US6068818A (en) | 1993-11-01 | 2000-05-30 | Nanogen, Inc. | Multicomponent devices for molecular biological analysis and diagnostics |
| ZA959469B (en) | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
| WO1997001603A1 (en) | 1995-06-26 | 1997-01-16 | Henkel Corporation | Methods of preparing inorganic pigment dispersions |
| US6001311A (en) | 1997-02-05 | 1999-12-14 | Protogene Laboratories, Inc. | Apparatus for diverse chemical synthesis using two-dimensional array |
| US7060431B2 (en) | 1998-06-24 | 2006-06-13 | Illumina, Inc. | Method of making and decoding of array sensors with microspheres |
| GB9817266D0 (en) | 1998-08-07 | 1998-10-07 | Imperial College | Method |
| US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
| JP2005204549A (ja) * | 2004-01-21 | 2005-08-04 | Hubit Genomix Inc | Ｃ型肝炎ウイルス感染者の経過に関する遺伝子およびその利用 |
| EP1778861A4 (en) * | 2004-07-01 | 2008-11-19 | Medical Res Fund At The Tel Av | METHODS AND KITS FOR PREDICTING THE SPEED OF PROGRESSION OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C |
| WO2010025380A2 (en) * | 2008-08-28 | 2010-03-04 | Vertex Pharmaceuticals Incorporated | Analysis of hcv genotypes |
| AU2010249379B2 (en) * | 2009-05-21 | 2013-09-26 | Merck Sharp & Dohme Corp. | Genetic markers associated with interferon-alpha response |
-
2010
- 2010-07-09 JP JP2012522282A patent/JP2013500713A/ja active Pending
- 2010-07-09 CN CN2010800436612A patent/CN102665753A/zh active Pending
- 2010-07-09 WO PCT/IB2010/053139 patent/WO2011013019A1/en not_active Ceased
- 2010-07-09 EP EP10740746A patent/EP2459210A1/en not_active Withdrawn
- 2010-07-09 MX MX2012001058A patent/MX2012001058A/es not_active Application Discontinuation
- 2010-07-09 KR KR1020127005379A patent/KR20120040725A/ko not_active Withdrawn
- 2010-07-09 CA CA2768772A patent/CA2768772A1/en not_active Abandoned
- 2010-07-09 BR BR112012001931A patent/BR112012001931A2/pt not_active IP Right Cessation
- 2010-07-09 AU AU2010277239A patent/AU2010277239A1/en not_active Abandoned
- 2010-07-29 US US12/846,356 patent/US20110165124A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Moreau et al. | Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland | |
| JP2012518421A5 (enExample) | ||
| CN104450963B (zh) | 一种hbv dna数字pcr定量检测试剂盒及其应用 | |
| Besse et al. | Genotyping and resistance profile of hepatitis C (HCV) genotypes 1–6 by sequencing the NS3 protease region using a single optimized sensitive method | |
| Nishimura et al. | Detection of noroviruses in fecal specimens by direct RT-PCR without RNA purification | |
| WO2009061640A3 (en) | Hepatitis b virus (hbv) specific oligonucleotide sequences | |
| WO2007016275A3 (en) | Methods and compositions for detecting bk virus | |
| CN101792800A (zh) | 多生物素信号放大方法 | |
| JP2011041526A5 (enExample) | ||
| Amini-Bavil-Olyaee et al. | Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine | |
| Cai et al. | Development of a novel genotype-specific loop-mediated isothermal amplification technique for Hepatitis B virus genotypes B and C genotyping and quantification | |
| Chantratita et al. | 6 HCV genotyping 9G test and its comparison with VERSANT HCV genotype 2.0 assay (LiPA) for the hepatitis C virus genotyping | |
| Vincenti et al. | A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations | |
| Saha et al. | A novel nested reverse-transcriptase polymerase chain reaction method for rapid hepatitis C virus detection and genotyping | |
| JP2014083052A5 (enExample) | ||
| Hasegawa et al. | Molecular epidemiology of hepatitis B virus in the United Republic of Tanzania | |
| Pabbaraju et al. | Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008) | |
| WO2009091148A3 (en) | Primer, probe, dna chip containing the same and method for detecting human papillomavirus and detection kit thereof | |
| Kao et al. | Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping | |
| WO2013093992A1 (ja) | Ｂ型肝炎ウイルス群を検出し、遺伝子多様性を評価するためのオリゴヌクレオチドのセット、並びにそれを用いた方法 | |
| Kareem et al. | Hepatitis C virus genotyping in Sulaimani Governorate | |
| CN102912035A (zh) | 一种通用型检测汉坦病毒实时荧光rt-pcr的非诊断性方法 | |
| ES2338853B1 (es) | Metodo y kit para la deteccion del virus de la hepatitis e (vhe). | |
| WO2007059348A3 (en) | Compositions and methods for detecting an hcv-1 subtype | |
| Lara et al. | Epistatic connectivity among hepatitis C virus genomic sites as genetic marker of interferon resistance |